Clinical trial
UARK 2001-37, A Phase I Exploratory Study of Combination PS-341 and Thalidomide in Refractory Multiple Myeloma
NCT00083460 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- UARK 2001-37, A Phase I Exploratory Study of Combination PS-341 and Thalidomide in Refractory Multiple Myeloma
- Lead sponsor
- University of Arkansas
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 31, 2001
- Completion date
- November 30, 2007
- Enrollment
- 86 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.